USPTO serial 79319289
TREEFROG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 27, 2022
- Examiner
- HARMON, RAYMOND E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TREEFROG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Todd A. Denys
Todd A. Denys Porzio, Bromberg & Newman, P.C.600 Alexander Road, Suite 2-1Princeton, NJ 08540UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research; stem cells for scientific purposes; nutrition agents for processing living cells other than for medical purposes; cell culture media for laboratory use, other than for medical purposes | ACTIVE | — |
| 005 | Pharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; stem cells for medical or veterinary use; pluripotent stem cells intended for cell and gene therapies for medical use; cell culture media for medical or veterinary use, namely, culture media for cultivating human cells and microorganism cells; surgical implants comprising living tissue obtained from stem cells | ACTIVE | — |
| 009 | Scientific apparatus for cell culture systems, namely cytometers and biomimetic 3D culture systems composed of cell culture dishes for cell culture systems; scientific apparatus for the analysis and sorting of cell culture, namely laboratory pipettes and capsules for the analysis and sorting of cell culture; bioreactors for cell culture; observation apparatus for cell culture, namely microscopes for cell culture; incubators for cell culture; cell culture apparatus for laboratory use, namely cell culture dishes and tissue culture flaks; downloadable computer software used for the collection, analysis, sorting and communication of biological information relating to stem cells | ACTIVE | — |
| 010 | Apparatus for the regeneration of stem cells for medical use; apparatus for cell culture systems for medical purposes, namely cell culture chambers and capsules; apparatus for encapsulation of cell culture systems for medical purposes; apparatus for analyzing and sorting cell culture for medical purposes | ACTIVE | — |
| 042 | Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TREEFROG THERAPEUTICS
- Other trademarks owned by TREEFROG THERAPEUTICS
- Other trademarks owned by TREEFROG THERAPEUTICS
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named TREEFROG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 14, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 23, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 23, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 27, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 27, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 27, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 12, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 12, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 29, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 29, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 22, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 6, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 6, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 4, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 4, 2022 | PBSR | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST | — |
| May 31, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 11, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 20, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 29, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 28, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 8, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 14, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 2, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |